Calcitonin versus clodronate in the prevention of ovariectomy-induced osteopenia in rats

Clinical Rheumatology

Volumn 19, Issue 1, 2000, Pages 47-50

  Rico, H ^a   Valencia, Ma J ^a   Villa, L F ^a   Hernandez E R ^a   Seco, C ^a   Sanchez Atrio A ^a   Revilla, M ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Biphosphonates; Bone mass; Clodronate; Ovariectomised rats; Salmon calcitonin

Indexed keywords

CALCITONIN; CLODRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MINERAL; CONTROLLED STUDY; DENSITOMETRY; FEMALE; FEMUR; LUMBAR VERTEBRA; MORPHOMETRICS; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; X RAY ANALYSIS;

ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; CALCITONIN; CLODRONIC ACID; DENSITOMETRY, X-RAY; DISEASE MODELS, ANIMAL; FEMALE; FEMUR; INJECTIONS, SUBCUTANEOUS; OVARIECTOMY; RATS; RATS, WISTAR; SPINE; TREATMENT OUTCOME;

EID: 0034006767     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050010     Document Type: Article

References (28)

1. Prestwood KM, Pilbeam CC, Raisz LG. Treatment of osteoporosis. Annu Rev Med 1995;46:249-56.
2. Frost HM, Jee WSS. On the rat model of human osteopenias and osteoporoses. Bone Miner 1992;18:227-36.
3. Wronski TJ, Yen CF, Qi H, Dann LM. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 1993;132:823-31.
4. Rico H, Amo C, Revilla M, Arribas I, González-Riola J, Villa LF, Rodriguez-Puyol M. Etidronate versus clodronate in the prevention of postovariectomy bone loss. An experimental study in rats. Clin Exp Rheumatol 1994;12:301-4.
5. Rico H, Alamo C, Revilla M, Villa LF, Alguacil LF. Effect of adjuvant-induced arthritis on bone mass in rats and its prevention by non-steroidal anti-inflammatory drugs (NSAIDs). Clin Exp Rheumatol 1992;10:595-597.
6. Mitlak BH, Schoenfeld D, Neer RM. Accuracy, precision, and utility of spine and whole-skeleton mineral measurements by DXA in rats. J Bone Miner Res 1994;9:119-26.
7. Garciamoreno C, Calvo OM, Herrero S, Martin E, Suquia B, Sanroman JI, et al. Heterogeneous decrease of bone mineral density in the vertebral column of ovariectomized rats. Bone 1995;16 (suppl 4):S295-300.
8. Holland EFN, Leather AT, Studd JWW. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants. Br J Obstet Gynaecol 1995;102:238-42.
9. Adami S, Passen M, Ortolani S, Broggini M, Carratelli L, Caruso I, et al. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis. Bone 1995;17:383-90.
10. Rosen HN, Tollin S, Balena R, Middlebrooks VL, Moses AC, Yamamoto M, et al. Bone density is normal in male rats treated with finasteride. Endocrinology 1995;136:1381-7.
11. Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991;15:175-92.
12. Rico H. Calcitonin and treatment of osteoporosis. J Med 1985;16:493-5.
13. Rico H, Hernández ER, Revilla M, Gómez-Castresana F. Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome. Bone Miner 1992;16:131-8.
14. a. Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study. Calcif Tissue Int 1995;56:181-5.
15. Wimalawansa SJ. Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study. Am J Med 1995;99:36-42.
16. Filipponi P, Pedetti M, Fedeli L, Cini L, Palumbo R, Boldrini S, et al. Cyclical clodronate is effective in preventing postmenopausal bone loss: a comparative study with transcutaneous hormone replacement therapy. J Bone Miner Res 1995;10:697-703.
17. Sontag W. Age-dependent morphometric alterations in the distal femora of male and female rats. Bone 1992;13:297-310.
18. Wronski TJ, Schenk PA, Cintron M, Walsh CC. Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int 1987;40:155-9.
19. Casez JP, Muehlbauer RC, Lippuner K, Kelly T, Fleisch H, Jaeger P. Dual-energy X-ray absorptiometry for measuring total bone mineral content in the rat: study of accuracy and precision. Bone Miner 1994;26:61-8.
20. Vaughan JM. The physiology of bone. Oxford: Clarendon Press, 1975:1-27.
21. Chappard D, Petitjean M, Alexandre C, Vico L, Minaire P. Riffat G. Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts. J Bone Miner Res 1991;6:673-80.
22. Giannini S, D'Angelo A, Sartori L, Passen G, Carbonare LD, Crepaldi G. Continuous and cyclical clodronate therapies and bone density in postmenopausal bone loss. Obstet Gynecol 1996;88:431-6.
23. Rizzoli R, Forni M, Schaad MA, Slosman DO, Sappino AP, Garcia J, Bonjour JP. Effects of oral clodronate on bone mineral density in patients with relapsing breast cancer. Bone 1996;18:531-7.
24. Kippo K, Hannuniemi R, Virtamo T, Lauren L, Ikavalko H, Kovanen V, et al. The effects of clodronate on increased bone turnover and bone loss due to ovariectomy in rats. Bone 1995;17:533-42.
25. Taube T, Elomaa I, Blomqvist C, Beneton MNC, Kanis JA. Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer. A histomorphometric study. Eur J Cancer 1993;29A:1677-81.
26. Ito N, Yamazaki H, Nakazaki M, Miyahara T, Kozuka H, Sudo H. Response of osteoblastic clonal cell line (MC3T3-E1) to (Asu 1,7) Eel calcitonin at a specific cell density or differentiation stage. Calcif Tissue Int 1987;40:200-5.
27. 3[H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast line cells. Calcif Tissue Int 1991;48:297-301.
28. Mundy GR. Calcium homeostasis: hypercalcemia and hypocalcemia. London: Martin Dunitz, 1989.